← FDA Drug Approvals (Drugs@FDA)
LEVETIRACETAM IN SODIUM CHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN LABS LTD · Approved 2026-05-08
Drug application
- FDA Application #
ANDA218364- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LEVETIRACETAM IN SODIUM CHLORIDE
- Generic name
- Levetiracetam
- Active ingredients
- LEVETIRACETAM
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- MYLAN LABS LTD
- First approval
- 2026-05-08
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown